Compared with the healthy controls, patients with COVID-19 showed an elevated level of ND1 mtDNA, an impaired platelet function, a plasmatic hypercoagulability (which is reflected by an increased A10, A20 and MCF) and impaired fibrinolysis. Here, MT-ND1 is linked to COVID-19.